Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system disorders, people familiar with the matter said.
Johnson & Johnson Is Exploring Bid for Intra-Cellular Therapies
Estimated read time
1 min read
You May Also Like
Doubting America Can Still Cost You a Lot of Money
January 13, 2025
Britain doesn’t need to walk a US or EU path on AI
January 13, 2025
China Developer That Led the Way on Debt Overhaul at Risk Again
January 13, 2025
More From Author
Palace knock out solid Stockport with Eze winner
January 13, 2025
Doubting America Can Still Cost You a Lot of Money
January 13, 2025
Solana (SOL) Teeters on the Edge: Is a Steep Decline Next?
January 13, 2025
+ There are no comments
Add yours